A previous study has evidenced significantly lower hepatic levels of SOD, catalase, and GPx and SOD activities in nonalcoholic fatty liver disease compared to serum levels of these enzymes, respectively [71]. This evidence concerns the gene SOD1 and metabolic dysfunction-associated steatotic liver disease.